Delivery Order SPE2DB22D9304-SPE2DB25FSTB9
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $37,137.60 by the Defense Logistics Agency (DLA) on August 21, 2025. The delivery order, which carries no set-aside designation, is for Xolair 150 mg/ml syringes with an ultimate completion date of September 12, 2025. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at approximately $142,000 by the Defense Logistics Agency (DLA) for XOLAIR 150 mg/ml syringes. The contract is firm fixed-price with an ultimate completion date of September 16, 2025, and was awarded on August 25, 2025, without set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,737.00 by the Defense Logistics Agency (DLA) on September 15, 2025, for the supply of Xolair 150 mg/ml syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 6, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $5,581.44 by the Defense Logistics Agency (DLA) for the supply of Xolair 300 mg/2 ml syringes. The delivery order, issued on September 10, 2025, carries an ultimate completion date of October 1, 2025, with no set-aside designation applied. This award represents a specific task order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $3,094.80 by the Defense Logistics Agency on August 27, 2025, for the supply of Xolair 150 mg/ml syringes. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Xolair 300 mg/2 ml auto-injector prefilled syringes. The contract, valued at $6,848.92 with a firm fixed-price structure, was awarded on August 13, 2025, with an ultimate completion date of September 4, 2025. This delivery order carries no set-aside designation and will be performed at the company's Park...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $8,561.10 by the Defense Logistics Agency for the supply of Xolair 150 mg/ml autoinjector. This firm fixed-price delivery order, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, was awarded without set-aside designation. The contract represents a single task order issued under DMS Pharmaceutical Group's larger...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,704.99 for Xolair 150 mg/ml by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a direct procurement with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $1,712.22 by the Defense Logistics Agency (DLA) for the supply of Xolair 150 mg/ml auto-injectors. The delivery order, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Xolair 75 mg/0.5 mL auto-injector vials. The contract, valued at $1,277.01 with a firm fixed-price structure, is scheduled for completion by September 24, 2025. This delivery order was awarded without set-aside designation on September 3, 2025, and represents a continuation of DMS Pharmaceutical Group's...
- SPE2DB22D9304Indefinite Delivery Contract
- SPE2DB22D9304-SPE2DB25FSTB9Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Xolair 150 mg/ml syringes with a ceiling value of $21,276.75. This firm fixed-price delivery order, issued on September 18, 2025, is expected to be completed by October 9, 2025. The award represents a specific procurement action executed under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA, valued at approximately $500 million and valid through November 2026. No set-aside designation was applied to this award. Xolair (omalizumab) is a monoclonal antibody used to treat moderate-to-severe allergic asthma and chronic idiopathic urticaria, making this delivery order part of the DLA's effort to ensure adequate pharmaceutical supplies for military health facilities nationwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts to deliver prescription medications, biologics, and medical consumables to Department of Defense healthcare sites. The company's extensive portfolio of federal awards demonstrates its capability to reliably supply specialized pharmaceutical products to support military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.3k | 9/18/25 |